PERIOPERATIVE HORMONAL-THERAPY IN LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE

被引：0

作者：

GRAHAM, SD

KEANE, TE

PETROS, JA

SANDERS, WH

机构：

[1] Division of Urology, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia

来源：

CANCER | 1995年 / 75卷 / 07期

关键词：

PROSTATE CANCER; HORMONAL THERAPY; NEOADJUVANT;

D O I：

10.1002/1097-0142(19950401)75:7+<1969::AID-CNCR2820751635>3.0.CO;2-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Perioperative hormonal therapy is a potential therapeutic strategy that combines the advantages of systemic therapy and local surgical control of adenocarcinoma of the prostate. In most cases, the use of hormonal therapy causes a reduction in the size of the prostate, some potential reduction in the volume of the cancer, and varying success in downstaging of the malignancy. No study has shown any benefit in either survival or reduction of recurrences.

引用

页码：1969 / 1971

页数：3

共 50 条

[41] Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma
Denberg, Thomas D.
Glode, L. Michael
Steiner, John F.
Crawford, E. David
Hoffman, Richard M.
BJU INTERNATIONAL, 2006, 98 (02) : 335 - 340
[42] Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer
Masato Sakamoto
Takashi Mizowaki
Michihide Mitsumori
Kenji Takayama
Keisuke Sasai
Yoshiki Norihisa
Toshiyuki Kamoto
Eijiro Nakamura
Osamu Ogawa
Masahiro Hiraoka
International Journal of Clinical Oncology, 2010, 15 : 571 - 577
[43] HORMONAL-THERAPY OF ADVANCE BREAST-CANCER - SEQUENTIAL TREATMENT, COMBINED HORMONAL MODALITIES, NEW DRUGS
WORST, P
ONKOLOGIE, 1991, 14 (03): : 218 - 227
[44] Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer
Sakamoto, Masato
Mizowaki, Takashi
Mitsumori, Michihide
Takayama, Kenji
Sasai, Keisuke
Norihisa, Yoshiki
Kamoto, Toshiyuki
Nakamura, Eijiro
Ogawa, Osamu
Hiraoka, Masahiro
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (06) : 571 - 577
[45] Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis
Neymark, N
Adriaenssen, I
Gorlia, T
Caleo, S
Bolla, M
Brochon, D
EUROPEAN JOURNAL OF CANCER, 2001, 37 (14) : 1768 - 1774
[46] Hormonal Therapy for Prostate Cancer
Desai, Kunal
McManus, Jeffrey M.
Sharifi, Nima
ENDOCRINE REVIEWS, 2021, 42 (03) : 354 - 373
[47] Radiation therapy for prostate cancer in the new S3 guideline - Part 1: localized and locally advanced prostate cancer
Boehmer, D.
Wenz, F.
Martin, T.
Sedlmayr, F.
Hinkelbein, W.
Wiegel, T.
UROLOGE, 2010, 49 (02): : 211 - 215
[48] Adenocarcinoma of an ileal conduit developing 8 years after cystoprostatectomy for locally advanced prostate carcinoma
Boettge, Katherina Renate
Paasch, Christoph
Schrader, Mark
Strik, Martin
BMJ CASE REPORTS, 2020, 13 (03)
[49] HORMONAL-THERAPY IN THE TREATMENT OF MANDIBULAR METASTASIS OF BREAST-CARCINOMA - REPORT OF A CASE
EHLINGER, P
PEETERS, LC
SERVAIS, J
FOSSION, E
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1993, 22 (02) : 108 - 109
[50] Neo-adjuvant hormonal therapy of prostate cancer
U. W. Tann
Urological Research, 1997, 25 (Suppl 2): : S57 - S62

← 1 2 3 4 5 →